The North America Chiral Chromatography Column Market is experiencing robust expansion driven by pharmaceutical advancements and a growing emphasis on enantiomeric purity. The market size was valued at USD 465 million in 2025 and is projected to reach USD 975 million by 2035, growing at a CAGR of 7.1% from 2024 to 2035. The U.S. remains the leading revenue generator, with significant adoption in pharmaceutical, biotechnology, and food testing industries. Rising applications in drug development and increasing R&D investments by major companies like Agilent Technologies and Waters Corporation further fuel market growth.
The economic impact of tariffs on "North America Chiral Chromatography Column Market".
Market Growth Drivers
Increasing Pharmaceutical R&D Investments: The continuous investment in drug discovery and development by major pharmaceutical companies such as Merck & Co. and Pfizer is a significant driver for the North America chiral chromatography column market. These companies rely on advanced chiral chromatography columns for precise enantiomeric separation during drug development, quality control, and synthesis of optically pure compounds. With growing FDA requirements for enantiomeric purity and the surge in demand for specialty drugs, the need for high-performance chiral columns has escalated. The expansion of the biopharmaceutical sector, innovation in column chemistries, and strategic collaborations among pharmaceutical giants and column manufacturers have sustainably increased market demand.
Growing Biotechnology Industry Usage: The rapid advancements in biotechnological research in North America, particularly in the U.S., are propelling the adoption of chiral chromatography columns. Companies such as Thermo Fisher Scientific and Sigma-Aldrich (now part of Merck Group) are at the forefront, leveraging these columns for analyzing and purifying complex biomolecules and chiral intermediates. Increased applications in biosimilars, personalized medicine, and life sciences research, coupled with government support for biotechnology innovation, are substantially contributing to market growth. The versatility and scalability of modern chiral columns meet the evolving requirements of laboratories and manufacturing environments.
Market Trends
Shift Towards Supercritical Fluid Chromatography (SFC): The industry is witnessing a pronounced shift towards green and efficient technologies such as supercritical fluid chromatography (SFC) for chiral separations. SFC provides faster separations, lower solvent consumption, and higher resolution—thus aligning with the growing need for sustainability and cost-saving initiatives within the sector. Companies like Waters Corporation are expanding their SFC column offerings, enabling greater throughput in pharmaceutical analysis and compound purification. This trend improves operational efficiency and supports regulatory compliance regarding solvent usage and waste management.
Integration of Automation and Digitalization: Automation and digitalization in chromatographic systems have become prominent trends in the market. Advanced chiral chromatography columns are now being integrated with automated sample handling systems, robotics, and data management tools. This integration boosts productivity, consistency, and traceability across laboratory workflows. Agilent Technologies recently introduced systems that combine innovative chiral columns with automation modules and analytical software, improving turnaround time and compliance. These advancements help laboratories meet increased regulatory demands while reducing human error and operational costs.
Market Opportunity
Expansion into Food and Beverage Industries: Growing concerns regarding food safety and authenticity are catalyzing new opportunities for chiral chromatography columns beyond pharmaceuticals and biotech. Leading companies like Shimadzu Corporation are collaborating with food testing laboratories to develop custom chiral column solutions for detecting enantiomeric adulteration and chiral contaminants in food products.
Emerging Applications in Cannabis Research: With the legalization and regulation of cannabis products across more U.S. states and in Canada, there is a rising demand for precise chiral analysis of cannabinoids and related compounds. This offers a substantial growth opportunity for providers of high-efficiency chiral columns such as Phenomenex, supporting regulatory compliance and product quality in the fast-growing cannabis research sector.
North America Chiral Chromatography Column Market Revenue (USD Million), 2020-2035
The revenue chart for the North America Chiral Chromatography Column Market from 2020 to 2035 illustrates a consistent upward growth trajectory. In 2020, the market was valued at approximately USD 305 million. It gradually increases year on year, driven by rising R&D investments, evolving regulatory standards, and expanding applications in pharmaceuticals, biotechnology, and food testing. By 2025, revenue is expected to cross USD 465 million, culminating in robust expansion to nearly USD 975 million by 2035. This pattern reflects a CAGR of about 7.1%, indicating strong confidence in the sector’s growth potential and continued innovation by major market players throughout the forecast period.
North America Chiral Chromatography Column Market by Regions Share (%), 2025
The pie chart for 2025 shows the United States as the dominant market, accounting for 71% of the regional market share. Canada follows with a significant 17% share, driven by growing pharmaceutical and cannabis research sectors. Mexico holds an 8% share, attributed to its developing life sciences industry. The remaining 4% is split among other North American territories, reflecting limited but emerging adoption. These figures highlight the central role of the U.S. in advancing chiral chromatography technologies and underline the opportunity for increased penetration in neighboring countries through better regulatory frameworks and industry collaborations.
Recent Developments
In March 2024, Waters Corporation launched the XBridge Premier Chiral OBD Prep Columns, specifically designed for high-throughput enantiomeric separations in pharmaceutical manufacturing. This new product line features advanced bonding techniques and improved load capacity, targeting process-scale purification. The launch demonstrates Waters’ commitment to facilitating more sustainable and efficient workflows in drug development pipelines across North America.
In February 2024, Agilent Technologies announced a strategic collaboration with a major biotechnology company to co-develop next-generation chiral columns tailored for biosimilar drug analysis. The partnership aims to fast-track the deployment of customized column innovations that align with the growing regulatory requirements for biosimilar characterization and trace enantiomer analysis. The collaboration leverages Agilent’s expertise in column design and the biotech firm’s deep pipeline of biologics.
In January 2024, Shimadzu Corporation unveiled upgraded chiral columns targeting food testing laboratories in North America. These columns offer improved sensitivity for enantiomer detection in food matrices and address rising demand for advanced analytical solutions to ensure food safety and regulatory compliance. With the recent growth in food authenticity testing and chiral adulterant screening, Shimadzu’s innovation responds to an emerging need within the region’s quality assurance and public health sectors.
Press Releases